Kura Oncology to host a virtual investor event today, October 18, 2025, at 10:30 a.m. PT / 1:30 p.m. ET / 7:30 p.m. CEST ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies ...

Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroups Median PFS was 15.5 months in the 120 mg palazestrant cohort across all patientsIn ...

Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with metastatic castration-resistant prostate cancer (mCRPC)No ...

Novel regimen GO-4, combining melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cells shows manageable adverse reactions and a strong signal of efficacy in patients with BRCA-relat ...

ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 continues to demonstrate a favorable safety and tolerability profileRegistrational studies planned to start in mid-2026Company ...

The Philippine lifestyle and media industries are mourning the loss of Susan Peña Joven, the trailblazing public relations icon and founder of Visions & Expressions, who passed away on October 17.

Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and ...

A clear and composed 'Hello everyone, I'm Mornine' ignited the climax of the 2025 Chery Global Innovation Conference.

University of Perpetual Help System DALTA returned to winning ways after escaping Jose Rizal University (JRU), 71-65, in the ...

Davao City Rep. Paolo Duterte slammed the Department of Justice (DOJ) for reversing its resolution that indicted former ...

LOOK: Perpetual Help def. JRU, 71-65 ...